Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Harm Reduction Journal|June 29, 2023
Community-based respondent-driven sampling as a strategy for drug use surveillance in a large French urban areaHélène Donnadieu, Catherine Quillet, Morgana D'Ottavi, et al.
Cells|August 26, 2023
Quantification of Female Chimeric Cells in the Tonsils of Male Children and Their DeterminantsBoris Dmitrenko, Vincent Gatinois, Morgana D'Ottavi, et al.
The Lancet. Global Health|January 25, 2025
Tuberculosis and people who use drugs: why focus on this overlooked population is important and why adapted interventions are necessaryMorgana D'Ottavi, Peter Godfrey-Faussett, Corinne S Merle, et al.
Open Forum Infectious Diseases|July 1, 2022
Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis CNicolas Nagot, Morgana D'Ottavi, Catherine Quillet, et al.
Biomedicines|July 27, 2022
Long-Term Persistence of Mitochondrial DNA Instability in HIV-Exposed Uninfected Children during and after Exposure to Antiretroviral Drugs and HIVValérie Desquiret-Dumas, Morgana D'Ottavi, Audrey Monnin, et al.
BMC Infectious Diseases|September 19, 2024
An optimized strategy triggered at the 2nd immunization visit to prevent HIV acquisition by breastfeeding: a phase 2 trial in Burkina Faso (PREVENIR-PEV)Anaïs Mennecier, Béninwendé Leticia Delphine Sakana, Morgana D'Ottavi, et al.
Bulletin of the World Health Organization|December 5, 2022
Prevention of mother-to-child transmission of HIV at the second immunization visit: a cross-sectional study, Burkina FasoBéninwendé Leticia Delphine Sakana, Anaïs Mennecier, Paulin Fao, et al.
AIDS (London, England)|January 5, 2024
Evaluation of the prevention of mother-to-child transmission of HIV programs at the second immunization visit in Burkina Faso and ZambiaSouleymane Tassembedo, Mwiya Mwiya, Anais Mennecier, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 28, 2024
Combination of serological and cytokine release assays for improved diagnosis of childhood tuberculosis in Zambia (PROMISE-TB)Edouard Tuaillon, Mwiya Mwyia, Karine Bollore, et al.
Lancet (London, England)|March 14, 2024
Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trialChipepo Kankasa, Anaïs Mennecier, Beninwendé L D Sakana, et al.
Pageof 2